Cholesterol treatment guidelines update

American Family Physician

Volumn 65, Issue 5, 2002, Pages 871-880

  Safeer, Richard S ^a,b,c   Ugalat, Prabha S ^a,b,c  

^a Trauma Critical Care Clinical   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; SIMVASTATIN;

AGE; ARTICLE; ATHEROSCLEROSIS; CIGARETTE SMOKING; DRUG COST; DRUG FORMULATION; FAMILY HISTORY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MALE; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION;

ADULT; ANTILIPEMIC AGENTS; CORONARY DISEASE; DIET, ATHEROGENIC; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIFE STYLE; MALE; MIDDLE AGED; PRACTICE GUIDELINES; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 0036500807     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms
2. Prevention of coronary heart disease through cholesterol reduction
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/Tex-CAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
5. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S)
6. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial
7. Sex-related differences in eligibility for reperfusion therapy and in-hospital outcome after acute myocardial infarction
8. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
9. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
10. Prevention Conference V: Beyond secondary prevention. Identifying the high-risk patient for primary prevention Medical office assessment. Writing Group I
11. Management of dyslipidemia in adults with diabetes. American Diabetes Association: Clinical Practice Recommendations 2000
12. CVD in patients with diabetes
13. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population
14. A meta-analysis of physical activity in the prevention of coronary heart disease
15. Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence study
16. Choosing drug therapy for patients with hyperlipidemia
17. Insulin resistance syndrome
18. Consensus development conference on insulin resistance. November 5-6, 1997
19. Insulin resistance in the pathogenesis of dyslipidemia